protoporphyrin ix has been researched along with fluorouracil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
Anand, S; Brankov, N; Brash, DE; Hasan, T; Maytin, EV; Rollakanti, KR | 1 |
Anand, S; Davis, SC; Denisyuk, A; Hu, B; Ishak, R; Karpinski, L; Kyei, A; Lohser, S; Maytin, EV; Riha, M; Sot, J; Tellez, A; Vidimos, A | 1 |
1 trial(s) available for protoporphyrin ix and fluorouracil
Article | Year |
---|---|
5-Fluorouracil Enhances Protoporphyrin IX Accumulation and Lesion Clearance during Photodynamic Therapy of Actinic Keratoses: A Mechanism-Based Clinical Trial.
Topics: Apoptosis; Biomarkers; Biopsy; Fluorouracil; Heme; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin | 2018 |
2 other study(ies) available for protoporphyrin ix and fluorouracil
Article | Year |
---|---|
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Fluorouracil Enhances Photodynamic Therapy of Squamous Cell Carcinoma via a p53-Independent Mechanism that Increases Protoporphyrin IX levels and Tumor Cell Death.
Topics: Animals; Biosynthetic Pathways; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Disease Models, Animal; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Heme; Humans; Mice; Photochemotherapy; Protoporphyrins; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |